Submit Deal

Announced

20 Aug 2024

Affidea to acquire Nu-Med from Enterprise Investors.

Synopsis

Affidea, a diagnostic imaging and community-based polyclinic and specialist healthcare services provider, agreed to acquire Nu-Med, a cancer care provider, from Enterprise Investors, a private equity firm. Financial terms were not disclosed.

Principals

target

NU-MED

bidder

AFFIDEA

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

mariusz borzęcki

CFO at NU-MED

Manager

target

Deal

n/a

Total Value

paweł paczkowski

Chairman of the Board at NU-MED

Manager

target

Deal

n/a

Total Value

łm

łukasz michalecki

‎Vice President at NU-MED

Manager

target

Deal

n/a

Total Value

Vendor Team (9)

michal rusiecki

Managing Partner at ENTERPRISE INVESTORS

Investor

vendor

Deals

£ 90 M

Total Value

kamila dyrkacz

Associate at BNP Paribas

Financial Advisor

vendor

Deals

n/a

Total Value

alexander tetzlaff

Managing Director at BNP Paribas

Financial Advisor

vendor

Deal

n/a

Total Value

tomasz ciborowski

Partner at ENTERPRISE INVESTORS

Investor

vendor

Deal

n/a

Total Value

krzysztof schabowski

Vice President at ENTERPRISE INVESTORS

Investor

vendor

Deal

n/a

Total Value

michal iwanicki

Managing Director at BNP Paribas

Financial Advisor

vendor

Deal

n/a

Total Value

alexandre bault

Managing Director at BNP Paribas

Financial Advisor

vendor

Deals

£ 64 M

Total Value

patryk kobak

Investment Banking Vice President at BNP Paribas

Financial Advisor

vendor

Deals

£ 534 M

Total Value

rita marques

Associate at BNP Paribas

Financial Advisor

vendor

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy